Holiday Hours:
Dec 24th, Dec 31st closing at 4pm.
Closed Nov 28th & Dec 25th.
Open Jan 1st!

Get Healthy!

Results for search "Weight Loss".

11 Nov

Popular Diabetes and Weight-Loss Drugs May Protect Stroke Survivors from Future Attacks, Study Finds

New research shows GLP-1 agonists, like Ozempic, and SGLT2 inhibitors, like Farxiga, help lower the risk of secondary stroke, heart attack and death in stroke survivors.

04 Sep

Taking Ozempic or Wegovy Does Not Increase Risk for Mental Health Issues, Study Finds

Researchers find no link between semaglutide, the main ingredient in Ozempic and Wegovy, and depression, suicidal thoughts or behaviors in patients with no prior history of the conditions.

Health News Results - 182

Zepbound Bests Wegovy for Weight Loss in New Trial

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.

"Given the increased interest around obesity medications, we conducted this study to help health care providers and patients make informed decisions about treatment choice," Dr. Leonard G...

Zepbound Slashes Diabetes Risk in Obese Users

The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found.

Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90% during a three-year period compared to placebo, trial res...

Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds

The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.

However, the move would have to be approved by the new Trump administration. 

Right now, a law passed b...

Study Finds GLP-1 Meds Can Also Help the Kidneys

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm.

In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes. 

GLP-1s include blockbuster diabetes medicines such as Ozempic and it...

Taking a GLP-1 Medication? Here's Tips to Holiday Eating

So, you have managed to shed 30 pounds with the help of one of the new blockbuster GLP-1 drugs, but as the holidays near you worry about how to handle gatherings where decadent food will be served in abundance.

Luckily, one expert from Baylor College of Medicine has tips on how to enjoy holiday fare while on these medications, without overdoing it.

GLP-1 medications, which include <...

Meds Like Ozempic Are Causing Folks to Waste More Food

America's kitchen trash bins are receiving more unwanted food as appetites falter among people taking GLP-1 weight-loss meds, a new study shows.

GLP-1s like Ozempic, Wegovy, Mounjaro and Zepbound

Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death

The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart attack or death, a new study says.

GLP-1 weight-loss drugs like Ozempic or SGLT2 diabetes medications like

  • Dennis Thompson HealthDay Reporter
  • |
  • November 11, 2024
  • |
  • Full Page
  • Unexplained Weight Loss and What It Can Mean for Your Health

    It may seem counter-intuitive, but losing weight without even trying may not be a good thing.

    "It's not typical to have a noticeable drop in weight without changing how much you're eating, being more physically active or trying to lose weight," said dietitian Christine Goukasian.

    "Unexplained weight loss is a red...

    Medicaid Covers GLP-1 Meds for Obesity in Just 13 States

    Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.

    Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.

    Under the Medicaid system, individual states are allowed to decide whether to cover GLP-1 drugs, which inclu...

    Ozempic, Wegovy Could Help Ease Knee Arthritis Pain

    The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found.

    People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after 68 weeks, compared with 3% of people given a placebo, results showed. The trial was fun...

    Ozempic Curbs Kidney Disease in Obese People Without Diabetes

    The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.

    Patients taking semaglutide -- the active agent in Ozempic and Wegovy -- had as much as a 52% reduction in kidney damage, as measured by urine testing, researchers reported Oct. 25 in the journal ...

    Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds

    As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds.

    Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds.

    "In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surg...

    Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes

    Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.

    People with type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer’s compared to patients taking seven other diabetes drugs, researchers reported...

    Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year

    Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year in the United States, a new study claims.

    Obesity and all its attendant ills -- type 2 diabetes, heart disease an...

    FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now

    Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.

    What prompted the FDA to reconsider its

  • Robin Foster HealthDay Reporter
  • |
  • October 15, 2024
  • |
  • Full Page
  • GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It

    As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.

    But a new study involving more than 54,000 U.S. adolescents found no such link.

    In fact, obese kids who used the drugs had a 33% decline in their risk for thoughts of suicide and suicide...

    Ozempic Plus Intestinal 'Zap' Therapy May Eliminate Need for Insulin in Type 2 Diabetics

    Results from a very small study suggest that a combination of the diabetes drug Ozempic and an innovative new intestinal procedure could help erase the need for insulin in folks with type 2 diabetes.

    The new trial hasn't yet been published in a peer-reviewed journal and it included only 14 patients.

    However, Dutch researchers report that after six months of the combo therapy, 12 o...

    Could Certain Genes Help You Slim Down?

    The key to weight loss could come down to a combination of 14 “skinny genes,” a recent study says.

    People with these genes dropped twice as much weight through regular exercise compared to those without the genes, researchers found.

    Those with the most of these genetic markers lost up to 11 pounds following eight weeks of

  • Dennis Thompson HealthDay Reporter
  • |
  • October 11, 2024
  • |
  • Full Page
  • Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees

    When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies cover the medications in their health insurance plans, a new survey shows.

    In a report published Wednesday in the journal Health Affairs, researchers also found that a third of compani...

    GLP-1 Weight-Loss Meds Could Interfere With Endoscopy, Colonoscopy

    Food left in the stomach or stool left in the bowel can impede a doctor's ability to successfully perform an endoscopy or colonoscopy.

    Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as Ozempic

    Could Ozempic Help Prevent Opioid Overdoses?

    In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose.

    People with type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower risk of an opioid OD t...

    Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

    During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company's high prices for its blockbuster drugs Ozempic and Wegovy.

    While testifying before the Senate Committee on Health, Education, Labor and Pens...

    Endurance Exercise Can Get Rid of Body Fat, Even Without Weight Loss

    Heavy-duty endurance exercise can cause body fat levels to drop without any accompanying weight loss, a new small-scale study indicates.

    A group of eleven middle-aged men who cycled 710 miles in seven days lost only about 1% of their total weight, because they ate and drank enough to offset the calorie burn.

    But they lost over 9% of their overall body fat, including a nearly 15% red...

    Cost Has Many Going Around Doctors to Get Weight-Loss Meds

    Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days.

    They’re in short supply, and often too expensive to afford without insurance coverage.

    Because of these barriers, many people are doing an end-run around their doctor’s office, reaching out ...

    Ozempic Could Curb Progression of Diabetes-Linked Liver Disease

    Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that.

    In a new decades-long study, veterans with diabetes and what's known as metabolic dysfunction-associated steatotic liver disease (MASLD) were 14% less likely to progress t...

    Ozempic or Saxenda for Weight Loss: Which Works Best?

    Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same hormone associated with blood sugar and appetite, a new study finds.

    Ozempic and Wegovy (semaglutide) promoted the loss of 10% or more body weight in 61% of people being treated for o...

    Ozempic, Mounjaro Help People With Type 1 Diabetes Control Blood Sugar, Lose Weight

    Initially approved to treat type 2 diabetes, Ozempic and Mounjaro also can help people with type 1 diabetes lose weight and control their blood sugar levels, a new study finds.

    Overweight or obese type 1 diabetics taking Mounjaro were able to reduce the amount of daily insul...

    In Every U.S. State, at Least 1 in 5 People Is Now Obese

    Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows.

    In 2013, not one state had an adult obesity rate topping 35%, but 10 years later 23 states had achieved that dubious distinction, according to data ...

    Weight-Loss Drug Zepbound May Work Better in Women Than Men

    The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval.

    All doses of tirzepatide consistently reduced weight in both women and men, researchers found.

    But women lost up to 25% of their initial body weight when treated with ti...

    Ozempic Can Prevent Heart Trouble in Folks With Kidney Issues

    Ozempic and Wegovy can prevent heart problems in overweight and obese people, particularly if they also suffer from kidney disease, a new clinical trial shows.

    The drugs’ active ingredient, semaglutide, reduced heart health risk by 20% in heavyset people who took it for more than three years...

    Weight-Loss Pill Saxenda Helps Kids as Young as 6

    The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report.

    The findings, published Tuesday in the New England Journal of Medicine and presented simultaneously at the European Association for the Study of Diabetes annual meeting in Madrid, are the f...

    Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug

    An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.

    People who took the drug amycretin lost up to 13% of their body weight over three months, according to early clinical trial results presented at the European Association for the Study of Diabetes annual meeting in Madrid.

    Amycretin mimics the action of two different hunger-related hormones...

    Obesity Raises Risk of Severe Infection, Especially in People With Diabetes

    Losing weight can help a person with obesity -- especially those with diabetes -- fend off serious infections, new data shows.

    It's an important finding, since "up to one in three hospitalizations in people with diabetes are for infections and people with diabetes are twice as likely to be hospitalized with infections than the general population. They are also at high risk of readmission,...

    Wegovy, Ozempic May Someday Be Given as Once-Monthly Injection

    A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.

    The new formulation encases semaglutide in a hydrogel that slowly releases the drug as the gel dissolves, researchers...

    Ozempic, Wegovy Won't Raise User's Suicide Risk, Study Finds

    The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy.

    But a new study rules out one possible problem -- using semaglutide does not increase a person&rsq...

    Taking Wegovy, Zepbound? One Expert Has Dietary Advice

    Folks taking weight-loss drugs like Wegovy or Zepbound might think they’ve found a shortcut to better health.

    But they still need to eat a high-quality diet if they want to maintain their well-being while they shed pounds, says a doctor with ...

    Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find

    New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.

    These two injected drugs are versions of semaglutide. In multiple new data analyses, the drugs appeared to cut people's odds for heart failure and its complications, reduce deaths from COVID-19 and lower deaths...

    Why Breast Feeding May Be Even Healthier for Heavier New Moms

    Breastfeeding helps women shed those extra pounds of "pregnancy weight," a new study finds, and the effect is even more pronounced for moms who were overweight before their pregnancy.

    Among women who exclusively breastfed their baby during its first year, women who were normal weight prior to pregnancy lost weight, but still retained about three extra pounds of their pregnancy weight, re...

    3.6 Million Americans Could Be Covered for Wegovy Under New Medicare Rules

    New Medicare rules could make 3.6 million Americans -- or even more -- eligible for treatment with the pricey weight-loss drug Wegovy, a new study finds.

    Under the new rules, the government will pay for Wegovy treatment if a person with high BMI also has heart disease.

    Until now, federal reg...

    Getting Fats From Plants Vs. Animals Boosts Your Life Span

    A study of more than 400,000 people tracked for up to 24 years finds that those who got their dietary fat from plants versus animals had significantly lower odds of dying during the study period.

    Plant-based fats' benefit included a reduced odds for deaths due to heart disease, the research showed.

    Conversely, the study "provides evidence that diets high in animal-based fats, includ...

    Cost Keeps Many Who Need Them  From Getting New Weight-Loss Meds

    WEDNESDAY, Aug. 7, 2024 (HealthDay news) -- Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds.

    Medicaid accounted for less than 10% of semaglutide (Ozempic, Wegovy) prescription fills in 2023, researchers ...

    Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger

    Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug.

    One study found U.S. prescriptions and refills of Ozempic (semaglutide) soari...

    Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic

    The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds. 

    New prescriptions for these drugs have doubled among people who have obesity but not diabetes, investigators...

    Four in 10 Cancer Cases, Nearly Half of Cancer Deaths Linked to Lifestyle

    Nearly half of cancer deaths and 4 of 10 cases of cancer are linked to a person's lifestyle, a new study says.

    Cigarette smoking remains the biggest cancer risk, contributing to 30% of cancer deaths and 20% of cancer cases, results show.

    But excess body weight, drinking, lack of exercise, diet and skipping cancer-preventing vaccinations also increase a person's risk of developing or...

    Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later

    Three of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.

    Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the review sifted through pharmacy and medical c...

    Mounjaro Bests Ozempic for Weight Loss

    Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.

    People taking tirzepatide (Mounjaro, Zepbound) dropped significantly more pounds than those taking semaglutide (O...

    Wegovy, Ozempic Lower Risk of Many Obesity-Related Cancers

    In yet another finding that touts the health benefits of wildly popular weight-loss medications like Wegovy and Ozempic, scientists report that taking the drugs may help reduce the risk of some cancers.

    In a study published July 5 in JAMA Network Open, researchers found people with type 2...

    Another Study Suggests GLP-1 Meds Could Ease Alcoholism

    Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says.

    People taking semaglutide had 50% to 56% decreased odds for either becoming alcoholic or relapsing into alcoholism, researchers reported recently in the journal Nature Communications.

    Few drugs are now available...

    Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms

    Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows.

    Both men and women showed improved heart function after a year on semaglutide, the active ingredient in Ozempic and Wegovy, researchers report.

    ...

    Healthy Weight Loss Could Lower Your Odds for Cancer

    Losing weight can protect you against cancers related to obesity, a new study finds.

    Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.

    But study results show that dropping pounds can improve a person's odds against developing these cancers, including

  • Dennis Thompson HealthDay Reporter
  • |
  • June 25, 2024
  • |
  • Full Page
  • Show All Health News Results